Interleukin-23 Promotes Interferon-α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients

M Odigie, A Osinusi, L Barrett, K Townsend… - AIDS research and …, 2014 - liebertpub.com
Patients coinfected with HIV and hepatitis C virus (HCV) have poor to modest rates of
response with interferon-based therapies, which remain a backbone of the treatment in …
被引用次数：11 相关文章

Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients.

M Odigie, A Osinusi, L Barrett, K Townsend… - AIDS Research and …, 2014 - europepmc.org
Patients coinfected with HIV and hepatitis C virus (HCV) have poor to modest rates of
response with interferon-based therapies, which remain a backbone of the treatment in …

Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients.

M Odigie, A Osinusi, L Barrett, K Townsend, HH Wang… - 2014 - cabidigitallibrary.org
Patients coinfected with HIV and hepatitis C virus (HCV) have poor to modest rates of
response with interferon-based therapies, which remain a backbone of the treatment in …
[HTML] nih.gov

[HTML][HTML] Inteleukin-23 Promotes Interferon-α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients

M Odigie, A Osinusi, L Barrett, K Townsend… - AIDS Research and …, 2014 - ncbi.nlm.nih.gov
Patients coinfected with HIV and hepatitis C virus (HCV) have poor to modest rates of
response with interferon-based therapies, which remain a backbone of the treatment in …

Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients

M Odigie, A Osinusi, L Barrett… - AIDS research and …, 2014 - pubmed.ncbi.nlm.nih.gov
Patients coinfected with HIV and hepatitis C virus (HCV) have poor to modest rates of
response with interferon-based therapies, which remain a backbone of the treatment in …